SK286162B6 - Stabilné soli kyseliny o-acetylsalicylovej s bázickými aminokyselinami - Google Patents
Stabilné soli kyseliny o-acetylsalicylovej s bázickými aminokyselinami Download PDFInfo
- Publication number
- SK286162B6 SK286162B6 SK67-2003A SK672003A SK286162B6 SK 286162 B6 SK286162 B6 SK 286162B6 SK 672003 A SK672003 A SK 672003A SK 286162 B6 SK286162 B6 SK 286162B6
- Authority
- SK
- Slovakia
- Prior art keywords
- amino acid
- basic amino
- acid
- composition according
- glycine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10034802A DE10034802A1 (de) | 2000-07-18 | 2000-07-18 | Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren |
PCT/EP2001/007669 WO2002005782A2 (fr) | 2000-07-18 | 2001-07-05 | Sels stables d'acide o-acetylsalicylique avec des acides amines basiques |
Publications (2)
Publication Number | Publication Date |
---|---|
SK672003A3 SK672003A3 (en) | 2003-06-03 |
SK286162B6 true SK286162B6 (sk) | 2008-04-07 |
Family
ID=7649258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK67-2003A SK286162B6 (sk) | 2000-07-18 | 2001-07-05 | Stabilné soli kyseliny o-acetylsalicylovej s bázickými aminokyselinami |
Country Status (34)
Country | Link |
---|---|
US (2) | US6773724B2 (fr) |
EP (1) | EP1365737B1 (fr) |
JP (2) | JP2004507463A (fr) |
KR (1) | KR100773658B1 (fr) |
CN (1) | CN1205176C (fr) |
AR (1) | AR030305A1 (fr) |
AT (1) | ATE293589T1 (fr) |
AU (2) | AU2001278471B2 (fr) |
BR (1) | BR0112538A (fr) |
CA (1) | CA2416288C (fr) |
CR (1) | CR6888A (fr) |
CZ (1) | CZ300337B6 (fr) |
DE (2) | DE10034802A1 (fr) |
DK (1) | DK1365737T3 (fr) |
EC (1) | ECSP034437A (fr) |
ES (1) | ES2241849T3 (fr) |
GT (1) | GT200100134A (fr) |
HK (1) | HK1061811A1 (fr) |
HR (1) | HRP20030108B1 (fr) |
HU (1) | HUP0302053A3 (fr) |
IL (2) | IL153873A0 (fr) |
MX (1) | MXPA03000510A (fr) |
MY (1) | MY134521A (fr) |
NO (1) | NO20030222L (fr) |
PE (1) | PE20020267A1 (fr) |
PL (1) | PL204593B1 (fr) |
PT (1) | PT1365737E (fr) |
RS (1) | RS50329B (fr) |
SK (1) | SK286162B6 (fr) |
SV (1) | SV2002000557A (fr) |
TW (1) | TWI299729B (fr) |
UY (1) | UY26841A1 (fr) |
WO (1) | WO2002005782A2 (fr) |
ZA (1) | ZA200300469B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
DE10202019A1 (de) * | 2002-01-18 | 2003-07-24 | Bayer Ag | Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II |
US8142810B2 (en) | 2002-05-30 | 2012-03-27 | The Procter & Gamble Company | Dietary method for modulating glucose metabolism and associated conditions and increasing longevity |
ATE442352T1 (de) * | 2003-05-16 | 2009-09-15 | Cephalon France | Verfahren zur herstellung von modafinil |
WO2006023844A2 (fr) * | 2004-08-20 | 2006-03-02 | Entremed, Inc. | Compositions et procedes comportant des antagonistes de recepteur active par la proteinase |
US20060166901A1 (en) * | 2005-01-03 | 2006-07-27 | Yu Ruey J | Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids |
DE102005025283A1 (de) * | 2005-06-02 | 2006-12-07 | Bayer Healthcare Ag | Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin |
DE102005049293A1 (de) * | 2005-10-15 | 2007-04-26 | Bayer Healthcare Ag | Kombinationspräparate von Salzen oder o-Acetylsalicylsäure |
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) * | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
EP2610242A1 (fr) | 2006-07-09 | 2013-07-03 | Techfields Biochem Co. Ltd | Promédicaments hydrosolubles positivement chargés d'aspirine |
US9371284B2 (en) | 2007-06-04 | 2016-06-21 | Techfields Pharma Co., Ltd. | Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses |
DE102008004386A1 (de) * | 2008-01-14 | 2009-07-23 | Activaero Gmbh | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
CN101314029B (zh) * | 2008-06-18 | 2010-12-08 | 四川省农业科学院实验场 | 乙酰水杨酸肽及其制备方法 |
WO2010056919A2 (fr) * | 2008-11-12 | 2010-05-20 | Kyphia Pharmaceuticals, Inc. | Promédicaments d'éflornithine, conjugués et sels, et procédés d'utilisation de ceux-ci |
KR20230085223A (ko) | 2008-12-04 | 2023-06-13 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
JP5706409B2 (ja) * | 2009-06-25 | 2015-04-22 | テトラ,エスイーアー | 新規なサリチル酸塩 |
CN101633624B (zh) * | 2009-08-04 | 2013-05-01 | 蚌埠丰原医药科技发展有限公司 | 改进的赖氨匹林的制备方法 |
FR2965261B1 (fr) * | 2009-09-30 | 2012-10-26 | Holis Technologies | Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede |
FR2950625B1 (fr) * | 2009-09-30 | 2016-12-02 | Holis Tech | Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue |
FR2973370B1 (fr) * | 2011-03-29 | 2013-05-03 | Holis Technologies | Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique |
CN102503845A (zh) * | 2011-09-28 | 2012-06-20 | 广州普星药业有限公司 | 一种dl-赖氨酸阿司匹林盐的制备方法及其应用 |
KR102309973B1 (ko) | 2012-05-16 | 2021-10-06 | 테크필즈 파마 코., 엘티디. | 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물 |
CN102976962B (zh) * | 2012-11-20 | 2015-02-04 | 南京工业大学 | L-鸟氨酸阿司匹林复盐及其制备方法和应用 |
FR3021654B1 (fr) | 2014-05-28 | 2016-06-24 | Unither Pharmaceuticals | Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique |
RU2764573C2 (ru) * | 2016-12-23 | 2022-01-18 | АспиЭйр ГмбХ | Улучшенный синтез частиц ацетилсалицилата лизина ⋅ глицина |
WO2018222583A1 (fr) * | 2017-05-30 | 2018-12-06 | Rho Pharmaceuticals, Llc | Dépôt en flacon d'acide o-acétylsalicylique (aspirine) stable, stérile et cristallin |
WO2019026992A1 (fr) * | 2017-08-03 | 2019-02-07 | 参天製薬株式会社 | Composition médicinale contenant de la chlorhexidine |
CN113105326A (zh) * | 2021-03-24 | 2021-07-13 | 海南卓华制药有限公司 | 赖氨匹林的制备方法及应用 |
CN114478287A (zh) * | 2021-12-31 | 2022-05-13 | 蚌埠丰原医药科技发展有限公司 | 一种赖氨匹林晶型及制备方法和应用 |
WO2023131645A1 (fr) | 2022-01-05 | 2023-07-13 | Aspiair Gmbh | Synthèse améliorée de particules d'acétylsalicylate de lysine · glycine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2115060A1 (en) * | 1970-11-26 | 1972-07-07 | Metabio | Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin |
ES388158A1 (es) * | 1971-02-11 | 1974-03-16 | Liade Sa Lab | Procedimiento de obtencion de sales solubles del acido ace-til salicilico. |
JPS4856815A (fr) * | 1971-11-13 | 1973-08-09 | ||
JPS55127345A (en) * | 1979-03-23 | 1980-10-02 | Kyowa Hakko Kogyo Co Ltd | Preparation of acetylsalicylic acid salt |
JPS5610110A (en) * | 1979-07-06 | 1981-02-02 | Green Cross Corp:The | Acetyl salicylate salt preparation for injection |
JPS56113741A (en) * | 1980-02-13 | 1981-09-07 | Mitsui Toatsu Chem Inc | Preparation of crystal of acetylsalicylic acid salt |
JPS5721345A (en) * | 1980-07-15 | 1982-02-04 | Mitsui Toatsu Chem Inc | Purification of acetylsalicylate salt |
CS247688B1 (cs) * | 1984-12-22 | 1987-01-15 | Evzen Kasafirek | Způsob výroby soli lysinu s kyselinou acetylsalicylovou |
JPS632929A (ja) * | 1986-06-20 | 1988-01-07 | Kao Corp | アセチルサリチル酸製剤 |
EP0499142A3 (en) * | 1991-02-09 | 1993-05-05 | Hoechst Aktiengesellschaft | Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs |
DE4332093C2 (de) * | 1993-09-22 | 1995-07-13 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung |
-
2000
- 2000-07-18 DE DE10034802A patent/DE10034802A1/de not_active Withdrawn
-
2001
- 2001-07-05 EP EP01956511A patent/EP1365737B1/fr not_active Expired - Lifetime
- 2001-07-05 JP JP2002511715A patent/JP2004507463A/ja active Pending
- 2001-07-05 CZ CZ20030164A patent/CZ300337B6/cs not_active IP Right Cessation
- 2001-07-05 PT PT01956511T patent/PT1365737E/pt unknown
- 2001-07-05 KR KR1020037000713A patent/KR100773658B1/ko not_active IP Right Cessation
- 2001-07-05 MX MXPA03000510A patent/MXPA03000510A/es active IP Right Grant
- 2001-07-05 CN CNB018158811A patent/CN1205176C/zh not_active Expired - Fee Related
- 2001-07-05 DK DK01956511T patent/DK1365737T3/da active
- 2001-07-05 IL IL15387301A patent/IL153873A0/xx unknown
- 2001-07-05 AT AT01956511T patent/ATE293589T1/de not_active IP Right Cessation
- 2001-07-05 ES ES01956511T patent/ES2241849T3/es not_active Expired - Lifetime
- 2001-07-05 RS YUP-20/03A patent/RS50329B/sr unknown
- 2001-07-05 WO PCT/EP2001/007669 patent/WO2002005782A2/fr active IP Right Grant
- 2001-07-05 HU HU0302053A patent/HUP0302053A3/hu unknown
- 2001-07-05 PL PL365648A patent/PL204593B1/pl not_active IP Right Cessation
- 2001-07-05 SK SK67-2003A patent/SK286162B6/sk not_active IP Right Cessation
- 2001-07-05 DE DE50105985T patent/DE50105985D1/de not_active Expired - Lifetime
- 2001-07-05 AU AU2001278471A patent/AU2001278471B2/en not_active Ceased
- 2001-07-05 AU AU7847101A patent/AU7847101A/xx active Pending
- 2001-07-05 CA CA002416288A patent/CA2416288C/fr not_active Expired - Fee Related
- 2001-07-05 BR BR0112538-9A patent/BR0112538A/pt not_active IP Right Cessation
- 2001-07-11 GT GT200100134A patent/GT200100134A/es unknown
- 2001-07-16 MY MYPI20013365A patent/MY134521A/en unknown
- 2001-07-16 UY UY26841A patent/UY26841A1/es not_active Application Discontinuation
- 2001-07-16 TW TW090117276A patent/TWI299729B/zh active
- 2001-07-16 US US09/906,497 patent/US6773724B2/en not_active Expired - Lifetime
- 2001-07-16 AR ARP010103378A patent/AR030305A1/es unknown
- 2001-07-17 SV SV2001000557A patent/SV2002000557A/es unknown
- 2001-07-17 PE PE2001000717A patent/PE20020267A1/es not_active Application Discontinuation
-
2003
- 2003-01-09 IL IL153873A patent/IL153873A/en not_active IP Right Cessation
- 2003-01-16 NO NO20030222A patent/NO20030222L/no not_active Application Discontinuation
- 2003-01-17 CR CR6888A patent/CR6888A/es unknown
- 2003-01-17 EC EC2003004437A patent/ECSP034437A/es unknown
- 2003-01-17 ZA ZA200300469A patent/ZA200300469B/en unknown
- 2003-02-17 HR HR20030108A patent/HRP20030108B1/xx not_active IP Right Cessation
-
2004
- 2004-07-07 HK HK04104934A patent/HK1061811A1/xx not_active IP Right Cessation
- 2004-08-09 US US10/915,652 patent/US7449198B2/en not_active Expired - Fee Related
-
2012
- 2012-03-28 JP JP2012072662A patent/JP2012131824A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK286162B6 (sk) | Stabilné soli kyseliny o-acetylsalicylovej s bázickými aminokyselinami | |
DE102005025283A1 (de) | Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin | |
KR20070026187A (ko) | 2개 이상의 활성 물질을 함유하는 주사용 멸균 약제학적제형 | |
CN103694172A (zh) | 含氮杂芳基化合物的衍生物 | |
FR2541287A1 (fr) | Preparation stable administrable par voie orale de macrolides antibiotiques et procede pour les stabiliser | |
AU2017259749C1 (en) | Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems | |
EP1469835B1 (fr) | Sels stables d'acide o-acetylsalicylique contenant des acides amines ii basiques | |
AU2004218728B8 (en) | Stable salts of O-acetylsalicyclic acid with basic amino acids | |
WO2005115404A1 (fr) | Combinaison de sels de l'acide o-acetylsalicylique et d'inhibiteurs d'alpha-glucosidase | |
CA2022447A1 (fr) | Forme galenique orale ameliorant la biodisponibilite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Assignment and transfer of rights |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, BERL, DE Free format text: FORMER OWNER: BAYER HEALTHCARE AG, LEVERKUSEN, DE Effective date: 20100614 |
|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20110705 |